Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Achillion Pharmaceuticals Company Profile (NASDAQ:ACHN)

Consensus Ratings for Achillion Pharmaceuticals (NASDAQ:ACHN) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.50 14.10% downside)

Analysts' Ratings History for Achillion Pharmaceuticals (NASDAQ:ACHN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/21/2014Credit SuisseReiterated RatingNeutral$4.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Deutsche BankUpgradeHold -> Buy$6.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2014Maxim GroupReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/15/2014FBR Capital MarketsInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014Piper JaffrayUpgradeNeutral -> Overweight$5.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014Wells Fargo & Co.UpgradeMarket Perform -> Outperform$7.36 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014JMP SecuritiesUpgradeMarket Perform -> Outperform$13.00ViewTweet This Rating  Share This Rating on StockTwits
6/23/2014Wells Fargo & Co.Boost Price Target$8.00ViewTweet This Rating  Share This Rating on StockTwits
6/16/2014Maxim GroupBoost Price TargetBuy$6.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2014Robert W. BairdUpgradeNeutral -> Outperform$4.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Deutsche BankBoost Price Target$6.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2014JMP SecuritiesUpgradeMarket Perform -> Outperform$13.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2014Edison Investment ResearchNeutralViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Maxim GroupUpgradeHold -> Buy$6.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013Credit SuisseDowngradeOutperform -> Neutral$11.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Deutsche BankDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Wells Fargo & Co.DowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Piper JaffrayDowngradeOverweight -> Neutral$15.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013William BlairDowngradeOutperform -> Market Perform$14.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Robert W. BairdDowngradeOutperform -> Neutral$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013JPMorgan Chase & Co.DowngradeOverweight -> Neutral$12.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013JMP SecuritiesDowngradeOutperform -> Market Perform$12.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Bank of AmericaDowngradeNeutral -> Underperform$10.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2013Robert W. BairdLower Price TargetOutperform$16.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2013JMP SecuritiesLower Price Target$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2013Leerink SwannReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
7/2/2013Maxim GroupDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/4/2013Piper JaffrayLower Price Target$15.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013Maxim GroupLower Price TargetBuy$23.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
2/22/2013William BlairLower Price Target$16.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Robert W. BairdReiterated RatingOutperform$17.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Robert W. BairdInitiated CoverageOutperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
12/26/2012Bank of AmericaReiterated RatingBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
12/13/2012Piper JaffrayReiterated RatingOverweight$16.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Wells Fargo & Co.Reiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Piper JaffrayReiterated RatingOverweight$16.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Deutsche BankReiterated RatingBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
9/28/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/23/2012 forward)
Discuss Achillion Pharmaceuticals